Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
Search
Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
More
Search
Home
Tags
Anvisa
Anvisa
Press Releases
Brazil Suspends Use of ELEVIDYS (delandistrogene moxeparvovec)
Editorials
Our Call to Anvisa: All Brazilian Children Over 7 Should Receive Elevidys Gene Therapy
Editorials
Brazilian Children Over 7 and Their Families Demand Elevidys Gene Therapy from Anvisa
Press Releases
Elevidys Gene Therapy has Arrived in Brazil and Could Cost up to 20 Million Brazilian Reais
Popular
Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy
DMD Warrior
-
December 26, 2024
Must Read
Editorials
Accredited Duchenne Centers (ADC) Aims to Provide Uniform and Up-to-date Care for All People Living with Duchenne Muscular Dystrophy
Research
RGX-202 Gene Therapy Phase 3 Clinical Trial Begins
Research
Entrada Therapeutics Begins Clinical Trials in Europe for Exon 44 and Exon 45 Skipping Therapies